Neighbourhood Pharmacies Supports Removing Clozapine Closed Distribution Requirements

Submission to Health Canada Marketed Health Products Directorate

Neighbourhood Pharmacies provided Health Canada with series of operational, economic and workflow recommendations to consider as it evaluates effectiveness and safety of the registry-based Clozapine controlled distribution program.

We believe the closed distribution model for Clozapine imposes unnecessary administrative burdens, disrupts patient care, and unfairly shifts costs and liability to community pharmacies. Neighbourhood Pharmacies is in favour of changes that lessen the administrative load while maintaining patient safety and fair access to Clozapine.

Read our submission for more information.

Submission to Health Canada